Barclays Upgrades Oscar Health Inc (OSCR) to Overweight, 'we see a visible path to an undemanding 13–15x P/E valuation'
Tweet Send to a Friend
(Updated - June 10, 2026 7:34 AM EDT)
Barclays analyst Andrew Mok upgraded Oscar Health Inc (NYSE: OSCR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst Andrew Mok upgraded Oscar Health Inc (NYSE: OSCR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
